Level D· Preclinical EvidenceLaboratory Study

Total synthesis of albafuran B and its osteogenic differentiation promoting effect on human mesenchymal stem cells.

Liu WD., Jing Y., Wang B., Tian LL., Li J., Yin XS.

Laboratory Study, published in J Asian Nat Prod Res (2026) — summary generated from the PubMed abstract.

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Asian Nat Prod Res (2026)
Country
England
Reported sample size
PMID
40459846
DOI
10.1080/10286020.2025.2509762

Abstract (original English)

In the current project, the total synthesis of albafuran B was achieved in four steps and 19.3% overall yield, involving two key reactions of the one-pot Corey-Fuchs reaction and Suzuki coupling. Using the same protocol, two analogs, moracin C and 4'-farnesyl-moracin M, were also successfully synthesized. The effect of albafuran B on the osteogenic differentiation of human umbilical cord-derived and adipose-derived mesenchymal stem cells was evaluated via alkaline phosphatase staining and alizarin red S staining. The assay results revealed that albafuran B showed good osteogenic differentiation promoting activity toward both cell lines.

What this study does not prove

  • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence comes from animal or laboratory studies and has not been confirmed in humans.

How we grade evidence